ADMA Biologics markets three FDA-approved immune globulin products, with ASCENIV serving as its main growth driver. My bull thesis centers on ADMA’s differentiated high-titer plasma sourcing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results